Driving Innovation in GI Together
As the world leader in single-use endoscopy, we remain as committed as ever to creating innovative products — and collaborating with experts in Gastroenterology to deliver the products you need. Our ability to iterate quickly is inherit to single-use design.
Of course, innovative products and solutions don’t come easily. That's why we invest heavily in research and development. And that’s why our product life cycle is much shorter than the six or more years for traditional reusable duodenoscopes. The aScope™ Duodeno, our single-use duodenoscope for ERCP procedures, underscores this superior R&D approach — as does our plan to launch 20 new single-use products over the next three years.
Sterile. Single-use. Problem solved.
Sterile straight from the pack, the Ambu® aScope™ Duodeno is a fully disposable, single-use duodenoscope for ERCP procedures. The aScope Duodeno is familiar in form and function, delivering reliable performance for clinicians.
We take pride in specializing in single-use endoscope manufacturing. In fact, our single-use endoscopes are used in more than 3,800 hospitals every year. And we’re excited to now bring our expertise and know-how to endoscopists in gastroenterology.
Recognizing Innovation: FDA Breakthrough Device Designation and Red Dot Award Winner
In July 2020, the aScope Duodeno endoscope received FDA clearance and was also granted Breakthrough Device Designation. The FDA's Breakthrough Device Program is reserved for certain medical devices that provide for more effective treatment or diagnosis of life-threatening or irreversibly debilitating diseases or conditions. This program is intended to help patients receive more timely access to these medical devices by expediting their development, assessment and review by FDA.
In addition, in April 2021 the aScope Duodeno was honored twice in the prestigious Red Dot Awards, in the categories of Product Design and Innovative Products.
aScope Duodeno Videos
Dr. Frank Gress: "a new innovative approach to interventional endoscopy"
Dr. Frank Gress is an interventional endoscopist who has been performing gastroenterology procedures for over 25 years. In this video, Dr. Gress evaluates Ambu’s new endoscope, the aScope Duodeno.
Dr. Todd Baron Assesses the aScope Duodeno for ERCP
Dr. Todd Baron is a therapeutic endoscopist who has performed more than 20,000 endoscopic retrograde cholangiopancreatography (ERCP) procedures. He offers a clinician’s assessment of Ambu’s new fully disposable duodenoscope, from its functionality to its impact on patient safety, productivity, and capital investment.
The True Cost of Reusable Duodenoscopes
Reusable duodenoscopes are $40,000 and used in patients for 5+ years at a time before being replaced. The aScope Duodeno is used just once. Watch the video above to compare the costs of reusable vs. single-use duodenoscopes.
Finally Address Concerns About Patient Cross-Contamination in ERCP
For decades, interventional endoscopists have used duodenoscopes to perform lifesaving ERCP procedures. There is, however, growing concern that even with the most stringent cleaning procedures, patient cross-contamination can occur with reusable duodenoscopes.
With the aScope Duodeno, you have a brand new sterile, single-use duodenoscope straight from the pack every time, and there is no risk of patient cross-contamination. What’s more, there’s no need for costly reprocessing or repairs.
Review the Evidence
View published peer-reviewed studies on contaminated duodenoscopes infectious outbreaks, clinical performance and health economics in our comprehensive Evidence Dossier. All studies support claims related to the Ambu aScope Duodeno.
aScope Duodeno CMS Reimbursement
Effective July 1, 2020, the Centers for Medicare & Medicaid Services (CMS) created a new transitional pass-through (TPT) category and new HCPCS C code for single-use endoscopes, such as the aScope Duodeno, used in performing ERCP procedures in the hospital outpatient department.
In addition, CMS has finalized approval of a New Technology Add-on Payment (NTAP) for the Ambu aScope Duodeno. Beginning Oct. 1, 2021, CMS will provide hospitals with additional device reimbursement when the aScope Duodeno is used for eligible cases in the hospital inpatient setting.
View our TPT Coding & Reimbursement Guide View our NTAP Guide